Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
26 juin 2017 mis à jour par: VA Office of Research and Development
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
This randomized control study tested the feasibility of two communication enhancement interventions: one with veterans who had a stroke and demonstrated poorly controlled hypertension; the other with VA primary care providers who provided routine outpatient medical care to these veterans.
This study intervened with both members of the provider-patient dyad in an attempt to improve the self-management of hypertension by improving communication during visits to the VA outpatient clinic, specifically by enabling veterans to communicate their questions and concerns about chronic disease self-management to their providers more effectively, and to help providers improve their ability to communicate more effectively with this population of veterans.
Aperçu de l'étude
Statut
Complété
Les conditions
Description détaillée
The communication intervention had two goals; (a) coaching to enhance veteran's abilities to communicate their questions and concerns about self-management for hypertension to their physician; and (b) improving provider's communication skills for enhancing and encouraging self-management of hypertension.
A health educator met with each participating veteran in the intervention arm prior to the 2nd visit to develop a plan for enhancing communication about self-management of hypertension.
The PI provided the Four Habits communication training to the 5 primary care providers in the intervention arm. Two clinic visits between each participating provider-patient pair were videotaped and coded.
This project had a goal of enrolling 10 VA primary care providers to participate in the randomized control trial and 30 veterans (3 veterans from the panel of each of the 10 participating providers) who had a stroke and now demonstrated poorly controlled hypertension. The study evaluated the difference between the two groups, and compared the content of the provider-patient conversations around hypertension management.
Type d'étude
Interventionnel
Inscription (Réel)
26
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Indiana
-
Indianapolis, Indiana, États-Unis, 46202-2884
- Richard L. Roudebush VA Medical Center, Indianapolis, IN
-
Indianapolis, Indiana, États-Unis, 46202-2884
- Richard Roudebush VA Medical Center, Indianapolis
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans à 99 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
Veteran:
- Veteran is a patient of the enrolled provider
- History of prior stroke
- Poorly controlled hypertension with at least one measurement >140/90 mm Hg in the past 12 months
- Complete a 6-item screen for cognitive and language impairment with a score of 3 or higher
- Sign the VA Media consent for use of picture and/or voice
Provider:
- Primary care provider, Medicine Service
- Sign VA media consent for use of picture and/or voice
Exclusion Criteria:
- Life expectancy is less than 6 months
- Non-English language patients
- Inability to provide informed consent
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Arm 1: Intervention-Veterans
Veterans enrolled in the "Intervention-Veterans" arm received a copy of the NIA guide for "Talking with Your Doctor" [Informational Guide for Patients].
Just prior to their next scheduled visit an educator met with each Veteran in the intervention arm individually for 20-30 minutes to review the material in the pamphlet and develop a plan for enhancing communication about self-management of hypertension with their doctor [Educational Coaching].
To facilitate communication change, the educator assisted the patient in setting a goal to achieve during their visit.
The educator also provided telephone follow-up within 24 hours to review satisfaction and effectiveness of the visit and assess barriers and facilitators to communicating about self-management.
|
Veterans received a copy of the NIA guide for "Talking with Your Doctor".
This pamphlet was specifically developed for this purpose (updated in 2002).
It has pictorials and is written at an 8th grade level.
an educator met with each Veteran in the intervention arm individually for 20-30 minutes to review the material in the pamphlet and develop a plan for enhancing communication about self-management of hypertension with their doctor [Coaching].
To facilitate communication change, the educator assisted the patient in setting a goal to achieve during their visit.
The educator also provided telephone follow-up within 24 hours to review satisfaction and effectiveness of the visit and assess barriers and facilitators to communicating about self-management.
|
|
Comparateur actif: Arm 2: Control-Veterans
Veterans enrolled in the "Control-Veterans" arm received a copy of the NIA guide for "Talking with Your Doctor" [Informational Guide for Patients].
This pamphlet was specifically developed for this purpose (updated in 2002).
It has pictorials and is written at an 8th grade level.
|
Veterans received a copy of the NIA guide for "Talking with Your Doctor".
This pamphlet was specifically developed for this purpose (updated in 2002).
It has pictorials and is written at an 8th grade level.
|
|
Expérimental: Arm 3: Intervention-Physicians
Primary care providers randomly assigned to the "Intervention-Physicians" arm of this study received a copy of the Four Habits of Highly Effective Physicians [Monograph for Physicians].
The Four Habits provided practical evidence-based advice for improving patient-physician communication.
Second, physicians participated in an audiotaped intensive 30 minute, one-on-one educational intervention with PI Frankel after their first set of visits from their three participating patients [Video-Assisted Coaching], but before seeing them for follow-ups.
The main goal of this meeting was to review and discuss the analysis of the physician's videotaped visits using the Four Habits framework, with a particular focus on improving communication about self-management.
|
Physicians participated in an audiotaped intensive 30 minute, one-on-one educational intervention with PI Frankel after their first set of visits from their three participating patients, but before seeing them for follow-ups.
The main goal of this video-assisted coaching session was to review and discuss the analysis of the physician's videotaped visits using the Four Habits framework, with a particular focus on improving communication about self-management.
Primary care providers randomly assigned to the "Intervention-Physicians" arm of this study received a copy of the Four Habits of Highly Effective Physicians.
The Four Habits provided practical evidence-based advice for improving patient-physician communication.
|
|
Comparateur actif: Arm 4: Control-Physicians
Primary care providers randomly assigned to the "Control-Physicians" arm of the study did not receive coaching or additional resources, and conducted their primary care practice as usual [Control].
|
The primary care providers randomly assigned to the "Control-Physicians" arm did not receive any additional coaching or resources and conducted their practice as usual.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Patient Activation Measure
Délai: 12 months
|
Veteran self-management of hypertension measured via the 13-item, (0-100 point range), Patient Activation Measure (PAM).
Administered at baseline (1st visit) and after each additional follow-up visit during the next 12-months (+2 max).
Rasch conversion changed raw scores to the PAM interval measure.
Reported outcome is difference in mean PAM scores at baseline and during 12-month follow-up.
If a participant had two PAM scores during the follow-up period, the average of the two was taken to calculate a combined follow-up score.
Higher PAM scores represent higher levels of self-activation.
Research on the PAM measure indicates that each point increase in PAM score correlates to a 2% decrease in hospitalization and a 2% increase in medication adherence.
Ranges for Baseline PAM scores: Intervention = 46.1 (min) to 84.3 (max); Control = 43.2
(min) to 77 (max).
Ranges for Follow-up PAM scores: Intervention = 48.4
(min) to 100 (max); Control = 45.1 (min) to 80.1 (max).
|
12 months
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Richard M. Frankel, PhD, Richard L. Roudebush VA Medical Center, Indianapolis, IN
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 septembre 2009
Achèvement primaire (Réel)
30 septembre 2012
Achèvement de l'étude (Réel)
30 janvier 2017
Dates d'inscription aux études
Première soumission
28 mai 2010
Première soumission répondant aux critères de contrôle qualité
1 juin 2010
Première publication (Estimation)
2 juin 2010
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
1 août 2017
Dernière mise à jour soumise répondant aux critères de contrôle qualité
26 juin 2017
Dernière vérification
1 juin 2017
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- RRP 09-190
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
produit fabriqué et exporté des États-Unis.
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .